A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure.
M W Rich, V Beckham, C Wittenberg...
https://pubmed.ncbi.nlm.nih.gov/7565975Completed
Phase 2
Age: 70Years - 100Years
All Genders
ID00000475
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2016-02-18
N/A
Participants Needed
N/A
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
To assess the impact of a multidisciplinary treatment program on three-month readmission-free survival in elderly congestive heart failure patients.
CONDITIONS
Official Title
Prevention of Early Readmission in Elderly Congestive Heart Failure Patients
Who Can Participate
Age: 70Years - 100Years
All Genders
Eligibility Criteria
You may qualify if you...
Men and women, ages 70 or older, with documented congestive heart failure.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Trial Site Locations
Site Locations not provided
Location information for this trial is currently unavailable.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
N/A
Allocation
RANDOMIZED
Model
N/A
Primary Purpose
PREVENTION
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Prevention of readmission in elderly patients with congestive heart failure: results of a prospective, randomized pilot study.
M W Rich, J M Vinson, J C Sperry...
https://pubmed.ncbi.nlm.nih.gov/8289096